°Ë»ö
ä¿ë
Á¤º¸
    ÇØ¿Ü¾à´ë Ãâ½Å 83¸í, ¾à»ç±¹½Ã º»´Ù...¿¹ºñ½ÃÇè ÇÕ°Ý·ü 46%
    ±â»çÀÔ·Â : 24.07.04 14:15:02
    0 °¡
    ÇÃÄ£Ãß°¡

    ±¹½Ã¿ø, Á¦5ȸ ¾à»ç¿¹ºñ½ÃÇè ÇÕ°ÝÀÚ¹ßÇ¥

    179¸í ÀÀ½ÃÇØ 83¸í ÇÕ°Ý...À۳⠴ëºñ ÇÕ°Ý·ü 20% »ó½Â

    [µ¥Àϸ®ÆÊ=Á¤ÈïÁØ ±âÀÚ] ÇØ¿Ü ¾à´ë Ãâ½Å 83¸íÀÌ ³»³â ¾à»ç±¹°¡°í½Ã ÀÀ½Ã ÀÚ°ÝÀ» ¾ò¾ú´Ù.

    ±¹½Ã¿øÀÌ ¿À´Ã(4ÀÏ) °øÁöÇÑ Á¦5ȸ ¾à»ç¿¹ºñ½ÃÇè °á°ú¿¡ µû¸£¸é ÇÕ°ÝÀÚ´Â ÀÀ½ÃÀÚ 179¸í Áß 83¸í·Î 46.4%ÀÇ ÇÕ°Ý·üÀÌ´Ù.

     ¡ãÇØ¿Ü¾à´ë Ãâ½Å 179¸í Áß 83¸íÀÌ ÇÕ°ÝÇß´Ù. ÇÕ°Ý·üÀº 46.4%´Ù.


    ¸Å³â ¿Ï¸¸ÇÏ°Ô »ó½ÂÇÏ´ø ÇÕ°Ý·üÀº ¿ÃÇØ ±ÞÁõÇß´Ù. 1ȸ ¿¹ºñ½ÃÇè¿¡¼­ 5.8%¿´´ø ÇÕ°Ý·üÀº ¼­¼­È÷ »ó½ÂÇØ ÀÛ³â 4ȸ ½ÃÇè¿¡¼­´Â 27.2%¸¦ ±â·ÏÇß´Ù. ¿ÃÇØ ÀÀ½ÃÀÚ°¡ ´Ã¾î³µ°í, ÇÕ°Ý·üÀº À۳⠴ëºñ ¾à 20% °¡±îÀÌ »ó½ÂÇϸ鼭 ÇÕ°Ý»ýÀÌ ´ë°Å ´Ã¾ú´Ù.

    ¸Å³â ¾à»ç¿¹ºñ½ÃÇè ÇÕ°ÝÀÚ Áß ±Ø¼Ò¼ö¸¦ Á¦¿ÜÇϰí´Â ¾à»ç±¹½Ã¿¡ ÇÕ°ÝÇÏ´Â Ãß¼¼´Ù. 1~3ȸÂ÷¿¡¼­´Â 1¸íÀ» Á¦¿ÜÇϰí´Â ±¹½Ã ÇÕ°ÝÇß´Ù.
    X
    AD
    ·Î°ÔÀÎÆû ¸ð¸àÅ͸® À̺¥Æ®Âü¿© ¡æ
    Á¤ÈïÁØ ±âÀÚ(jhj@dailypharm.com)
    ±ÛÀÚÅ©±â ¼³Á¤
    °¡³ª´Ù¶ó¸¶¹Ù»ç
    °¡³ª´Ù¶ó¸¶¹Ù»ç
    °¡³ª´Ù¶ó¸¶¹Ù»ç
    • ¼­¿ïƯº°½Ã Á¾·Î±¸ ÀÓ±âÁ¦°ø¹«¿ø(¾à»ç) ÀÓ¿ë°èȹ Àç°ø°í ¹Ù·Î°¡±â
    • °æ·ÂÁ÷ MRä¿ë (¼öµµ±Ç) ¹Ù·Î°¡±â
    • Senior Associate, PV (Pharmacovigilance) ¹Ù·Î°¡±â
    • º»»ç ½ÅÀÔ RA ¾à»ç ä¿ë ¹Ù·Î°¡±â
    • º»»ç Medical Affairs ä¿ë(°ø°í¿¬Àå) ¹Ù·Î°¡±â
    • 2025³â »ó¹Ý±â ¼ö½Ãä¿ë(ÇмúÀÇÇнÇ, BDÆÀ ¾à»ç) ¹Ù·Î°¡±â
    • RA, PMS, MSL ,PM, MR, MM µî °¢ ºÎ¹® ¸ðÁý ¹Ù·Î°¡±â
    • ÃæºÏ À½¼º Á¦Á¶°ü¸®¾à»ç ä¿ë ¹Ù·Î°¡±â
    • °­¸ª°øÀå Á¦Á¶°ü¸®¾à»ç °æ·Â¹«°ü ¹Ù·Î°¡±â
    • Sr. RA Specialist & RA Specialist (2 Year Contract) ¹Ù·Î°¡±â
    • [Á¦¾à»ç¾÷ºÎ¹®] °³¹ßÆÀ(RA) ¾à»ç ½ÅÀÔ/°æ·Â ä¿ë ¹Ù·Î°¡±â
    • Á¤±ÔÁ÷ ¾à¹«Á÷(ÆÀÀå) ¾à»ç ä¿ë °ø°í ¹Ù·Î°¡±â
    • Çâ³² °øÀå Á¦Á¶°ü¸®¾à»ç °æ·Âä¿ë ¹Ù·Î°¡±â
    • [Çѵ¶] Çѵ¶ÇコÄÉ¾î °æ¿µ°ü¸®, MA, Ãѹ« ÆÀÀå, Á¦Á¶°ü¸® ¾à»ç, ÀÌÈ­ÇнÃÇè(QC), ±â¼úÆÀ ±³Á¤´ã´ç, Àü¹®ÀǾàǰ ¸¶ÄÉÆÃ, ÀϹÝÀǾàǰ ¸¶ÄÉÆÃ ¹Ù·Î°¡±â
    0/300
     
    ¸ÞÀϺ¸³»±â
    ±â»çÁ¦¸ñ : ÇØ¿Ü¾à´ë Ãâ½Å 83¸í, ¾à»ç±¹½Ã º»´Ù...¿¹ºñ½ÃÇè ÇÕ°Ý·ü 46%